首页> 外国专利> USE OF DESIGNER RECEPTORS EXCLUSIVELY ACTIVATED BY DESIGNER DRUGS IN THE TREATMENT OF SEIZURE DISORDERS

USE OF DESIGNER RECEPTORS EXCLUSIVELY ACTIVATED BY DESIGNER DRUGS IN THE TREATMENT OF SEIZURE DISORDERS

机译:在药物性疾病治疗中使用设计师药物独家激活的设计师受体

摘要

Methods and compositions for treating a seizure disorder are provided which include administering to the patient a vector encoding a modified receptor for delivery of the modified receptor to the target location, the modified receptor being modified to be activated by a synthetic ligand, wherein the modified receptor inhibits neuronal firing when activated; and administering to the patient the synthetic ligand. Also provided are methods and compositions for treating a seizure disorder in a patient in need thereof by administering to the patient a vector encoding a modified receptor for delivery of the modified receptor to the target location, the modified receptor being modified to be activated by a synthetic ligand, wherein the modified receptor increases neuronal firing when activated; and administering to the patient the synthetic ligand. The methods are used to improve or alleviate one or more symptoms of a seizure disorder.
机译:提供了用于治疗癫痫病的方法和组合物,其包括向患者施用编码修饰受体的载体,用于将修饰受体递送至靶标位置,修饰受体被修饰以被合成配体激活,其中修饰受体激活后抑制神经元放电;并向患者施用合成配体。还提供了通过向患者施用编码修饰受体以将修饰受体递送至靶标位置的载体来治疗有需要的患者的癫痫症的方法和组合物,所述修饰受体被修饰以通过合成激活配体,其中修饰的受体在激活时增加神经元的放电;并向患者施用合成配体。该方法用于改善或缓解癫痫发作的一种或多种症状。

著录项

  • 公开/公告号CA3056410A1

    专利类型

  • 公开/公告日2018-09-20

    原文格式PDF

  • 申请/专利权人 OVID THERAPEUTICS INC.;

    申请/专利号CA20183056410

  • 发明设计人 DURING MATTHEW;

    申请日2018-03-15

  • 分类号A61K31/5513;A61P3/04;A61P25/14;A61P25/28;

  • 国家 CA

  • 入库时间 2022-08-21 12:47:22

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号